Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Gallo: Systemic, Mucosal & Passive Immunity |
| Strategy: | Combo: DNA & protein vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2009-07-27 |
| Study Made Public: | 2012-02-24 |
Title
Neutralization activity of sera from rhesus macaques immunized with a conformationally constrained gp120 immunogen.
Description
CAVD 303 is a non-human primate study comparing DNA/protein prime/boost regimens with a conformationally constrained gp120 immunogen, rhFLSC.
Sign in to see full information about this study and to download study data.
Products
rhFLSC Protein rhFLSC DNA GLA-SE (IDRI-EM005) A1-VectorIntegrated data
NAb
Non-integrated data
No non-integrated data is available for this study.